Cancer enzyme in pancreatic cancer

Our researchers in the Japanese city of Nagoya have discovered an enzyme to combat pancreatic cancer.

Pancreatic cancer, known professionally as pancreatic carcinoma, is a malignant tumor that affects the pancreas. Patients suffering from pancreatic cancer complain of the following non-specific symptoms:

Weight loss in approximately 90 percent of all cases

Abdominal or back pain in approximately 80 percent of patients

Jaundice (approximately 70 percent)

Loss of appetite and nausea (40–50 percent)

New-onset diabetes mellitus (15 percent)

Vomiting (15 percent)

Thrombosis: blockage of body veins by blood clots (27 percent)

What are the causes and risk factors?

Certain factors and lifestyle circumstances can increase the risk of developing the disease:

Smoking

Obesity

Chronic pancreatitis (recurrent inflammation of the pancreas)

Type 2 diabetes

Family cancer risk

Older age

The pancreas has two tissues, the exocrine and the endocrine, to perform its functions. In the exocrine tissue, the glandular cells produce digestive juices, which are transported to the intestine via the pancreatic ducts. The endocrine tissue contains hormone-producing cells that produce hormones such as insulin. These hormones are needed to regulate blood sugar levels. Tumors can form in any of these tissues.

With the help of our cancer enzyme, the spread and growth of malignant tumors in the pancreas can be specifically slowed.

We recommend taking one capsule twice daily.